Table 4.
Therapeutic effects of the treatments for improvement of primary Sjögren syndrome with ocular surface inflammation.
| 95% CI | ||||
|---|---|---|---|---|
| Treatments | ß | Lower | Upper | p |
| Oral pilocarpine | 1.050 | 1.000 | 1.102 | 0.092 |
| Low-dose oral steroid | 1.250 | 0.875 | 1.745 | 0.278 |
| Tear substitutes | ||||
| Carbomer gel | 0.986 | 0.888 | 1.094 | 0.786 |
| Lanoline ointment | 1.097 | 0.948 | 1.269 | 0.214 |
| Diquafosol 3% | 1.012 | 0.924 | 1.108 | 0.800 |
| Topical cyclosporine | 1.084 | 0.980 | 1.199 | 0.098 |
| Steroid eye drops (frequency dependent) | ||||
| Prednisolone 1% | 1.477 | 1.292 | 1.688 | <0.001 * |
| Loteprednol 0.5% | 1.390 | 1.076 | 1.798 | 0.012 * |
| Fluorometholone 0.1% | 1.245 | 1.149 | 1.350 | <0.001 * |
| Punctal plug insertion | ||||
| Lower eyelid | 2.257 | 1.927 | 2.643 | <0.001 * |
| Upper eyelid | 1.702 | 1.402 | 2.067 | 0.002 * |
Adjustment for corneal staining score. * p < 0.05.